Sera Prognostics Q3 net loss narrows

Sera Prognostics

13/11/2025 21:18

Overview

Sera Prognostics Q3 2025 revenue was $16,000

Net loss for Q3 2025 was $7.8 mln, slightly improved from last year

Company progresses on Medicaid pilot in Nevada, engaging with multiple payers

Outlook

Company is advancing discussions with Medicaid plans covering 33% of U.S. births

Company aims to secure broad coverage at employer, plan, and state levels

Result Drivers

Research and development expenses for the third quarter of 2025 were $3.3 million, compared to $3.5 million for the third quarter of 2024

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$16,000
Q3 Net Income
-$7.81 mln
Q3 Basic EPS
-$0.16
Q3 Income from Operations
-$8.98 mln
Q3 Operating Expenses
$9 mln


Analyst Coverage

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the business support services peer group is "buy."

Press Release: ID:nPnsdX29a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)